Personalised pulmonary rehabilitation in COPD

European Respiratory Review

Volumn 27, Issue 147, 2018, Pages

  Wouters, Emiel F M ^a,b   Wouters, Birgit B R E F ^a   Augustin, Ingrid M L ^b   Houben Wilke, Sarah ^b   Vanfleteren, Lowie E G W ^a   Franssen, Frits M E ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CIRO+   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SELECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; DNA SEQUENCE; EPIGENETICS; GENETICS; HUMAN; IMAGING; INFORMATION SCIENCE; METABOLOMICS; MICROBIOMICS; OMICS; PERSONALIZED MEDICINE; PHENOTYPE; PROTEOMICS; PUBLIC-PRIVATE PARTNERSHIP; PULMONARY REHABILITATION; REVIEW; SELF CARE; SHARED DECISION MAKING; SPIROMETRY; TRANSCRIPTOMICS; CONVALESCENCE; DOCTOR PATIENT RELATION; LUNG; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT PARTICIPATION; PROCEDURES; RESPIRATORY CARE; RISK FACTOR; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HUMANS; LUNG; PATIENT PARTICIPATION; PATIENT-CENTERED CARE; PHYSICIAN-PATIENT RELATIONS; PRECISION MEDICINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECOVERY OF FUNCTION; RESPIRATORY THERAPY; RISK FACTORS; TREATMENT OUTCOME;

EID: 85051670447     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0125-2017     Document Type: Review

References (47)

1. Speizer FE, Ware JH. Exploring different phenotypes of COPD. N Engl J Med 2015; 373: 185–186.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD – 2016. http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/
3. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 693–718.
4. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645–1648.
5. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728–735.
6. Vanfleteren L, Spruit MA, Wouters EFM, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med 2016; 4: 911–924.
7. Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 2013; 107: 1376–1384.
8. Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 2016; 47: 410–419.
9. Hodgkin JE, Farrell MJ, Gibson SR, et al. American Thoracic Society. Medical Section of the American Lung Association. Pulmonary rehabilitation. Am Rev Respir Dis 1981; 124: 663–666.
10. Plsek PE, Wilson T. Complexity, leadership, and management in healthcare organisations. BMJ 2001; 323: 746–749.
11. Simpkin AL, Schwartzstein RM. Tolerating uncertainty – the next medical revolution? N Engl J Med 2016; 375: 1713–1715.
12. Bean R. Sir William Osler: Aphorisms from His Bedside Teachings and Writings. New York, Henry Schuman, 1950.
13. Annegarn J, Meijer K, Passos VL, et al. Problematic activities of daily life are weakly associated with clinical characteristics in COPD. J Am Med Dir Assoc 2012; 13: 284–290.
14. Vaes AW, Wouters EFM, Franssen FME, et al. Task-related oxygen uptake during domestic activities of daily life in patients with COPD and healthy elderly subjects. Chest 2011; 140: 970–979.
15. Stoilkova A, Janssen DJ, Franssen FM, et al. Coping styles in patients with COPD before and after pulmonary rehabilitation. Respir Med 2013; 107: 825–833.
16. Papava I, Oancea C, Enatescu VR, et al. The impact of coping on the somatic and mental status of patients with COPD: a cross-sectional study. Int J Chron Obstruct Pulmon Dis 2016; 11: 1343–1351.
17. Fraser DD, Kee CC, Minick P. Living with chronic obstructive pulmonary disease: insiders’ perspectives. J Adv Nurs 2006; 55: 550–558.
18. Wouters EF, Augustin IM. COPD health-care delivery: a holistic and dynamic approach is needed. Lancet Respir Med 2016; 4: e30–e31.
19. Kaljouw M, van Vliet K. Moving Towards New Health Care and New Health Care Professions: the Contours. 2016. https://english.zorginstituutnederland.nl/publications/reports/2015/04/10/moving-towards-new-health-careand-new-health-care-professions-the-contours
20. Huber M, Knottnerus JA, Green L, et al. How should we define health? BMJ 2011; 343: d4163.
21. PHG Foundation. Many Names for One Concept or Many Concepts in One Name? www.phgfoundation.org/file/ 13380 Date last accessed: June 6, 2017.
22. National Cancer Institute. Personalized Medicine. www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=561717 Date last accessed: June 6, 2017.
23. President’s Council of Advisors on Science and Technology. Priorities for Personalized Medicine. September 2008. http://oncotherapy.us/pdf/PM.Priorities.pdf
24. Scholz N. Personalised Medicine: the Right Treatment for the Right Person at the Right Time. 2015. www.europarl.europa.eu/RegData/etudes/BRIE/2015/569009/EPRS_BRI%282015%29569009_EN.pdf Date last accessed: June 6, 2017.
25. Mancinelli L, Cronin M, Sadée W. Pharmacogenomics: the promise of personalized medicine. AAPS PharmSci 2000; 2: E4.
26. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol 2012; 29: 613–624.
27. Jameson JL, Longo DL. Precision medicine – personalized, problematic, and promising. N Engl J Med 2015; 372: 2229–2234.
28. National Research Council. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington, DC, The National Academies Press, 2011.
29. Xie H, Frueh F. Pharmacogenomics steps toward personalized medicine. Pers Med 2005; 2: 325–337.
30. Topol EJ. Individualized medicine from prewomb to tomb. Cell 2014; 157: 241–253.
31. FORUM Academy of Medical Sciences. Stratified, Personalised or P4 Medicine: a New Direction for Placing the Patient at the Centre of Healthcare and Health Education. 2015 https://acmedsci.ac.uk/viewFile/564091e564072d564041.pdf Date last accessed: June 6, 2017.
32. Wilson T, Holt T, Greenhalgh T. Complexity science: complexity and clinical care. BMJ 2001; 323: 685–688.
33. Ziegelstein RC. Personomics. JAMA Intern Med 2015; 175: 888–889.
34. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182: 598–604.
35. Pinto LM, Alghamdi M, Benedetti A, et al. Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res 2015; 16: 50.
36. Bourbeau J, Pinto LM, Benedetti A. Phenotyping of COPD: challenges and next steps. Lancet Respir Med 2014; 2: 172–174.
37. Kosteli MC, Heneghan NR, Roskell C, et al. Barriers and enablers of physical activity engagement for patients with COPD in primary care. Int J Chron Obstruct Pulmon Dis 2017; 12: 1019–1031.
38. Fishman AP. Pulmonary rehabilitation research. Am J Respir Crit Care Med 1994; 149: 825–833.
39. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13–e64.
40. Lusuardi M, Ambrosino N, Donner C. Definition and rationale for pulmonary rehabilitation. In: Donner C, Ambrosino N, Goldstein R, eds. Pulmonary Rehabilitation. London, Arnold, 2005; pp. 3–8.
41. Augustin I, Spruit M, Franssen F, et al. Understanding complexity of chronic non-communicable diseases: an integrated approach for personalized management of patients with COPD. Clin Res Pulmonol 2015; 3: 1034–1042.
42. Spruit MA, Augustin IM, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J 2015; 46: 1625–1635.
43. Elwyn G, Laitner S, Coulter A, et al. Implementing shared decision making in the NHS. BMJ 2010; 341: c5146.
44. World Health Organization (WHO). Building a Working Definition of Partnership. 2009. www.who.int/ patientsafety/implementation/apps/resources/defining_partnerships-apps.pdfDate last accessed: Nov 6, 2017.
45. Bauman AE, Fardy HJ, Harris PG. Getting it right: why bother with patient-centred care? Med J Aust 2003; 179: 253–256.
46. Lorig K. Partnerships between expert patients and physicians. Lancet 2002; 359: 814–815.
47. Knowledge@Wharton. Precision Medicine: New Paradigms, Risks and Opportunities. 2016 http://d1c25a6gwz7q5e. cloudfront.net/reports/2016-08-22-Precision-Medicine-New-Paradigms-Risks-and-Opportunities.pdf Date last accessed: June 6, 2017.